Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence-Reference-Cited by-同舟云学术

Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence

Published:2013-09-06 Issue:1 Volume:15 Page:13-22
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

McAllister J¹,Read P²³,McNulty A²⁴,Tong WWY¹,Ingersoll A¹,Carr A¹

Affiliation:

1. HIV, Immunology & Infectious Diseases Unit; St Vincent's Hospital; Sydney Australia

2. Sydney Sexual Health Centre; Sydney Hospital; Sydney Australia

3. The Kirby Institute; University of New South Wales; Sydney Australia

4. School of Public Health and Community Medicine; University of New South Wales; Sydney Australia

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference33 articles.

1. Updated U.S. Public Health Service guidelines for the management of occupational exposure to HIV and recommendations for postexposure prophylaxis;Panlilio;MMWR Morb Mortal Wkly Rep,2005

2. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States;Smith;MMWR Morb Mortal Wkly Rep,2005

3. UK guideline for the use of post exposure prophylaxis for HIV following sexual exposure;Benn;Int J STD AIDS,2011

4. NPEP Reference Group Australian national guidelines for post-exposure prophylaxis after non-occupational exposure to HIV (draft) www.ashm.org.au/ 2013

5. Prevention of SIV infection in macaques by (R)-9-(2-Phosphonylmethoxypropyl) adenine;Tsai;Science,1995

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and rates of infection by HIV in people receiving non-occupational post-exposure prophylaxis (nPEP) against HIV;Sexually Transmitted Infections;2024-05-13

2. Post-exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions;The Lancet HIV;2023-12

3. Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV;BMC Infectious Diseases;2023-09-04

4. Adherence to HIV post-exposure prophylaxis in a specialized service in São Paulo, Brazil;The Journal of Infection in Developing Countries;2023-06-30

5. The Use of HIV Pre- and Postexposure Prophylaxis Among a Web-Based Sample of HIV-Negative and Unknown Status Cisgender and Transgender Sexual Minority Men: Cross-sectional Study;JMIR Public Health and Surveillance;2022-12-16